BPTF expression was significantly higher in HR group [median, 0.428 vs. 0.288 (non-high-risk group), P = 0.017], stage IV group [median, 0.446 vs. 0.283 (I-III / IVs group), P = 0.012], and NB children with BM metastasis group [median, 0.428 vs. 0.293 (non-BM metastases group), P = 0.046, Fig. 7A-C]. This evidence concerns the gene BPTF and neuroblastoma.